Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?

Pierre-Yves Scarabin; Marianne Canonico; Geneviève Plu-Bureau; Emmanuel Oger

doi:10.1136/heartjnl-2020-316907

Journal articles

Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?

Pierre-Yves Scarabin ^{1, *} Marianne Canonico ^{2, 1} Geneviève Plu-Bureau ³ Emmanuel Oger ⁴

* Corresponding author

1 CESP - Centre de recherche en épidémiologie et santé des populations

2 UVSQ - Université de Versailles Saint-Quentin-en-Yvelines

3 UPCité - Université Paris Cité

4 REPERES - Recherche en Pharmaco-épidémiologie et Recours aux Soins

Keywords : coronary artery disease epidemiology stroke thromboembolic pulmonary vascular disease

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Gynecology and obstetrics

Life Sciences [q-bio] / Human health and pathology / Endocrinology and metabolism

Complete list of metadata

Cited literature [4 references] Display Hide Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02862267
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, July 7, 2020 - 11:39:15 AM
Last modification on : Friday, August 5, 2022 - 11:55:01 AM
Long-term archiving on: : Friday, November 27, 2020 - 1:07:34 PM

Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?

File

Identifiers

Collections

Citation

Export

Metrics

191

182

Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?

File

Identifiers

Collections

Citation

Export

Share

Metrics

191

182